16 results
·
21ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
HEMOSIL ANTITHROMBIN
FDA 510(k)
FDA Class 2
·Hematology
Vial Adaptor
FDA UDI
WEST PHARMA. SERVICES IL, . LTD·07290108240160·Vial Connector 13mm FLL Orange- VF
Paltop
FDA UDI
PALTOP ADVANCED DENTAL SOLUTIONS LTD·07290108694109·Pilot Guided Drill Spade
Paltop
FDA UDI
PALTOP ADVANCED DENTAL SOLUTIONS LTD·07290108699203·Titanium Base Abutment Round Anterior, Int. Hex...
CollaFlex
FDA UDI
UNICARE BIOMEDICAL INC.·D767C0703010·Resorbable COLLAFLEX® membranes are derived fro...
LINEAR ST
FDA Adverse Event
Injury
·BOSTON SCIENTIFIC NEUROMODULATION·Product code LGW·February 19, 2020
MODIFICATION TO VISTA STEREOSCOPE SYSTEM
FDA 510(k)
FDA Class 2
·Gastroenterology, Urology
IMMUNOWELL EA (D) IGG TEST
FDA 510(k)
FDA Class 1
·Microbiology
COSYCOT INFANT WARMER
FDA Adverse Event
Malfunction
·FISHER & PAYKEL HEALTHCARE, LTD.·Product code FMT·January 20, 2010
HIGH FREQUENCY VENTED HUMIDIFICATION CHAMBER
FDA Adverse Event
Malfunction
·FISHER & PAYKEL HEALTHCARE, LTD.·Product code BTT·June 4, 2008
ONETOUCHPING GLUCOSEMGMTSYSTEM
FDA Adverse Event
Malfunction
·ANIMAS CORPORATION·Product code LZG·April 22, 2013
TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM
FDA Adverse Event
Injury
·BOSTON SCIENTIFIC - GALWAY·Product code NIQ·April 27, 2011
GE OEC 9800
FDA Adverse Event
Malfunction
·GE OEC MEDICAL SYSTEM INC.·Product code JAA·July 9, 2008
AFP ¿1-FETOPROTEIN
FDA Adverse Event
Malfunction
·ROCHE DIAGNOSTICS·Product code LOJ·July 22, 2016
Aurora Series, Aurora 7 lighthead; Models: LED7 (including TV models). The Aurora Series is intended to illuminate the surgical field and ensure visibility of the surgical site.
FDA Enforcement
Class II
·Ongoing·DKK Dai-Ichi Shomei Co., Ltd.·August 21, 2024
CADD-Solis VIP ambulatory Infusion Pumps, Model 2120 (21-2120, 21-2125, and 21-2127) Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.
FDA Enforcement
Class I
·Ongoing·Smiths Medical ASD Inc.·August 14, 2024